Jazz Pharmaceuticals (JAZZ)
NASDAQ: JAZZ
· Real-Time Price · USD
117.73
-0.03 (-0.03%)
At close: Aug 18, 2025, 3:59 PM
117.50
-0.20%
Pre-market: Aug 19, 2025, 08:03 AM EDT
Jazz Pharmaceuticals Revenue
Jazz Pharmaceuticals reported an annual revenue of $4.07B, reflecting a 6.12% growth. For the quarter ending June 30, 2025, Jazz Pharmaceuticals generated $1.05B in revenue.
Revenue (ttm)
4.07B
Revenue Growth
6.12%
Price / Sales Ratio
1.87
Revenue / Employee
1.45M
Employees
2,800
Market Cap
7.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 4.07B | +6.12% |
| Dec 31, 2023 | 3.83B | +4.78% |
| Dec 31, 2022 | 3.66B | +18.26% |
| Dec 31, 2021 | 3.09B | +30.91% |
| Dec 31, 2020 | 2.36B | +9.34% |
| Dec 31, 2019 | 2.16B | +14.32% |
| Dec 31, 2018 | 1.89B | +16.82% |
| Dec 31, 2017 | 1.62B | +8.79% |
| Dec 31, 2016 | 1.49B | +12.32% |
| Dec 31, 2015 | 1.32B | +12.95% |
| Dec 31, 2014 | 1.17B | +34.44% |
| Dec 31, 2013 | 872.42M | +48.88% |
| Dec 31, 2012 | 585.98M | +115.21% |
| Dec 31, 2011 | 272.28M | +56.68% |
| Dec 31, 2010 | 173.78M | +35.29% |
| Dec 31, 2009 | 128.45M | +90.26% |
| Dec 31, 2008 | 67.51M | +3.39% |
| Dec 31, 2007 | 65.3M | +45.58% |
| Dec 31, 2006 | 44.86M | +109.20% |
| Dec 31, 2005 | 21.44M | +Infinity% |
| Dec 31, 2004 | 0 | n/a |